Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
119
days
Characterization of unusual pyrazole ring-rearranged metabolites of DS-1971a specific to monkeys
AuthorsDaigo Asano; Kazuyoshi Michiba; Kayoko Masuda; Takashi Ohnuki; Makoto Suzuki; Tetsuya Suzuki; Hideyuki Shiozawa; Tsuyoshi Shinozuka; Toshio Takatsu; Daisuke Nakai
AffiliationsDrug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Modality Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Modality Research Laboratories II, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Discovery Science and Technology Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan; Analytical & Quality Evaluation Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Corporate Planning Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Center for Pharmaceutical and Biomedical Analysis, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan
93
days
Development of a method for vancomycin monitoring in interstitial fluid using a novel porous microneedle array patch
AuthorsJo Terauchi; Taisei Kawamura; Jongho Park; Kiyomi Saito; Masataka Tajima; Hitoshi Sato; Beomjoon Kim; Erika Sugiyama
AffiliationsDepartment of Pharmacokinetics and Pharmacodynamics, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan; Department of Precision Engineering, School of Engineering, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8656, Japan; Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo, 153-8505, Japan; Innovation Center for Cannabinoid Research, Faculty of Pharmacy, Mahidol University, Bangkok, 10400, Thailand
63
days
Development and validation of LC–MS-based bioanalytical methods for oligonucleotide therapeutics: points to consider
AuthorsYuchen Sun; Kosuke Saito; Shin-ichiro Nitta; Ryoya Goda; Yuki Kishino; Hisashi Fujita; Masaaki Kakehi; Yoshiharu Hayashi; Satoshi Ito; Tomomi Ishida; Kiyomi Kikuchi; Kazuko Inoue; Kazutaka Shimbo; Takeru Yamaguchi; Fumihiro Jinno; Kaori Murakoshi; Chie Murata; Kentaro Takahara; Mitsuhiko Kawabata; Ruri Kikura-Hanajiri; Yoshiro Saito
AffiliationsDivision of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa, 210-9501, Japan; Mediford Corporation, 1-15-10 Shimura, Itabashi-ku, Tokyo, 174-0056, Japan; Future Peak Co., Ltd., 3-48 Imainakamachi, Nakahara-ku, Kawasaki City, Kanagawa, 211-0065, Japan; Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan; Takeda Pharmaceutical Co., Ltd., 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-8555, Japan; CMIC Pharma Science Co., Ltd., 17-18 Nakahatacho, Nishiwaki City, Hyogo, 677-0032, Japan; Sekisui Medical Co., Ltd., 2117 Muramatsu, Tokai-mura naka-gun, Ibaraki, 319-1182, Japan; Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, 300-2635, Japan; Ajinomoto Co., Inc., 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki City, Kanagawa, 210-8681, Japan; Sumika Chemical Analysis Service, Ltd., 3-1-135 Kasugadenaka, Konohana-ku, Osaka City, Osaka, 554-0022, Japan; Axcelead Drug Discovery Partners, Inc., 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-0012, Japan; Tanabe Pharma Corporation, 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-8555, Japan; Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamotocho, Mishima-gun, Osaka, 618-8585, Japan; Thermo Fisher Scientific K.K., 3-9 Moriyacho, Kanagawa-ku, Yokohama City, Kanagawa, 221-0022, Japan; Shin Nippon Biomedical Laboratories Ltd., 16-1 Minamiakasaka, Kainan-city, Wakayama, 642-0017, Japan; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa, 210-9501, Japan
168
days
A permeability assay adapted for the assessment of very poorly permeable compounds in the bRo5 space
AuthorsPaulina Page; Dallas Bednarczyk
AffiliationsPharmacokinetic Sciences, Novartis Institutes of BioMedical Science, Cambridge, MA, USA
124
days
A novel scaling approach for human pharmacokinetic prediction of antibody-drug conjugates using minimal nonclinical data: Integration of monkey PK and in vitro data
AuthorsSatoshi Nakayama; Nao Torimoto; Toshiyuki Kudo; Kiyomi Ito
AffiliationsDMPK Research Laboratories, Research Division, Tanabe Pharma Corporation, 1000, Kamoshida-cho Aoba-ku, Yokohama-shi, Kanagawa, 227-0033, Japan; Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan
44
days
K2-EDTA anticoagulant suppresses calcium-dependent paraoxonase 1-mediated hydrolysis in human plasma stability assays
AuthorsLloyd Wei Tat Tang
AffiliationsPharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, CT, USA
105
days
Role of the arachnoid mater organic anion and cation transporters in the clearance of prostaglandin D2 and metformin from the cerebrospinal fluid in rats
AuthorsYuka Yaguchi; Kazunari Sasaki; Mai Inagaki; Tetsuya Terasaki; Masanori Tachikawa
AffiliationsGraduate School of Pharmaceutical Sciences, Tokushima University, 1-78-1 Sho-machi, Tokushima, 770-8505, Japan; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8578, Japan; Graduate School of Biomedical Sciences, Tokushima University, 1-78-1 Sho-machi, Tokushima, 770-8505, Japan; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, 70210, Finland; Institute of Photonics and Human Health Frontier, Tokushima University, 2-24, Shinkura-cho, Tokushima, 770-8501, Japan
87
days
Differences in reactive metabolite formation and cytochrome P450 binding between acetaminophen and its bicyclo[1.1.1]pentane bioisostere
AuthorsMinami Shibata; Ayato Mizuno; Tomoki Nakayoshi; Akifumi Oda; Masaya Nakajima; Masanobu Uchiyama; Masahiro Hiratsuka; Yoshihiro Yamanishi; Kouichi Yoshinari
AffiliationsLaboratory of Molecular Toxicology, Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan; Laboratory of Biophysical Chemistry, Graduate School of Pharmacy, Meijo University, Nagoya, Japan; Institute for Advanced Research, Nagoya University, Nagoya, Japan; Advanced Elements Chemistry Laboratory, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan; Laboratory of Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Department of Complex Systems Science, Graduate School of Informatics, Nagoya University, Nagoya, Japan; Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan
103
days
Physiologically-based pharmacokinetic modeling of coproporphyrin I, an endogenous OATP1B substrate, in cynomolgus monkeys: Bridging the inhibitory effect of rifampicin to humans
AuthorsTakashi Yoshikado; Yukana Tomoda; Kouki Kasai; Reiki Toda; Satofumi Iida; Koji Chiba
AffiliationsLaboratory of Clinical Pharmacology, Yokohama University of Pharmacy, 601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, 245-0066, Japan
186
days
Microfluidic post-insertion preparation and evaluation of RGD- and PEG-modified macrophage-derived small extracellular vesicles
AuthorsMizuki Umino; Longjian Geng; Yusuke Ushiroda; Makoto Matsumoto; Hidefumi Mukai; Shigeru Kawakami
AffiliationsSchool of Pharmaceutical Sciences, Nagasaki University, 1-14 Bunkyo, Nagasaki-shi, Nagasaki, 852-8521, Japan; Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8588, Japan; Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8588, Japan
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days